Bluejay Diagnostics Partners with Argonaut for US Manufacturing
Bluejay Diagnostics announced a strategic partnership with Argonaut Manufacturing Services to advance its Symphony™ platform. This collaboration aims to establish scalable U.S.-based manufacturing capabilities, strengthen commercial infrastructure, and enhance supply chain resilience. The partnership is crucial for supporting Bluejay's ongoing clinical development programs and future commercialization objectives for its near-patient diagnostic solutions, particularly the IL-6 Test for sepsis.
Key Highlights
- Bluejay Diagnostics partnered with Argonaut Manufacturing Services for Symphony™ platform.
- Partnership aims to establish scalable U.S.-based manufacturing capabilities.
- Intends to strengthen commercial infrastructure and product distribution across the U.S.
- Designed to enhance supply chain resilience and reduce international sourcing risks.
- Supports Bluejay's clinical development and future commercialization objectives.
- Focuses on the Symphony™ platform, including the IL-6 Test for sepsis.
Price Impact
More from BJDX
Bluejay Diagnostics Completes SYMON-II Clinical Trial Enrollment for 750 Patients
Bluejay Diagnostics Completes Enrollment for SYMON-II Clinical Study
Bluejay Diagnostics Stockholders Approve Reverse Split, Increase Stock Plan Shares